Global Intrauterine Devices Market Size By Type (Hormonal IUD, Copper IUD), By Application (Age 20-24, Age 25-34), By Region, And Segment Forecasts, 2023 to 2032

The Global Intrauterine Devices (IUDs) Market was valued at USD 4.2 billion in 2023 and is projected to surpass USD 7.8 billion by 2031, growing at a CAGR of 7.9% during the forecast period of 2023-2031. The market growth is primarily driven by rising awareness of contraceptive methods, increasing government initiatives for family planning, and the growing demand for long-term and reversible contraception options.

IUDs are one of the most effective forms of birth control, offering a high success rate of over 99% with long-term use. With advancements in product designs and increasing adoption of hormone-based IUDs, the market is witnessing a surge in demand across developed and developing economies.

Market Drivers

1. Growing Awareness of Contraceptive Methods

There is a significant rise in awareness about modern contraceptive techniques, particularly in emerging economies, fueled by government initiatives and non-profit programs that educate women about family planning.

2. Increasing Demand for Long-Term and Reversible Contraception

IUDs offer a highly effective and reversible contraceptive solution, making them an attractive option for women looking for long-lasting birth control without permanent sterilization. The rising preference for hormone-based IUDs, which provide additional benefits like reduced menstrual bleeding, is further driving demand.

3. Government Family Planning Initiatives

Many governments, especially in developing regions, are subsidizing IUDs and promoting family planning programs, leading to higher adoption rates.

4. Advances in Product Design and Materials

Technological advancements such as smaller, more comfortable IUDs and copper-free non-hormonal alternatives are enhancing patient experience and reducing side effects, making IUDs more appealing.

Market Restraints

1. Misconceptions and Cultural Barriers

Despite rising awareness, myths and misconceptions about IUDs, including infertility concerns and pain-related fears, pose challenges to adoption in certain regions.

2. Risk of Side Effects

Potential side effects such as irregular bleeding, cramping, and device expulsion may deter some users and lead to hesitation among first-time adopters.

3. Limited Availability in Rural Areas

In developing regions, accessibility to trained healthcare professionals who can properly insert and remove IUDs remains a major challenge, restricting market penetration.

Market Opportunity

1. Expansion in Emerging Markets

The Asia-Pacific and Latin America regions present significant opportunities for IUD manufacturers due to rising healthcare infrastructure development and government-backed contraceptive programs.

2. Development of Newer, More Comfortable IUDs

Companies are investing in next-generation IUDs that offer less invasive insertion, improved efficacy, and reduced side effects, which can boost adoption rates.

3. Growing Adoption of Hormonal IUDs

There is a noticeable shift towards hormonal IUDs, which offer additional benefits such as lighter periods and reduced menstrual pain, broadening the target market.

Market by Product Type Insights

1. Copper IUDs

Copper IUDs held the largest market share in 2023, driven by their cost-effectiveness, non-hormonal nature, and long lifespan of up to 10 years. They are preferred by women looking for hormone-free birth control options.

2. Hormonal IUDs

Hormonal IUDs are the fastest-growing segment due to their additional health benefits, including lighter periods and reduced menstrual cramps. Leading brands such as Mirena and Skyla are dominating this space.

Market by End-Use Insights

1. Hospitals & Specialty Clinics

Hospitals and specialty clinics held the largest market share due to the presence of trained professionals who ensure safe insertion and removal of IUDs.

2. Family Planning Centers

Governments and NGOs are increasingly partnering with family planning centers to distribute free or subsidized IUDs, driving growth in this segment.

3. Online Pharmacies

Online sales of self-insertion IUDs (under medical supervision) are gaining traction, particularly in developed regions.

Market by Regional Insights

1. North America

North America dominated the market in 2023, accounting for over 35% of the revenue share, driven by high awareness, availability of advanced products, and increasing preference for hormonal IUDs.

2. Europe

Europe remains a key market due to government-backed contraceptive initiatives and a strong emphasis on reproductive health.

3. Asia-Pacific

The fastest-growing region, fueled by rising population control measures, increasing healthcare spending, and government efforts to promote contraceptive use.

4. Latin America & Middle East & Africa

Although adoption rates are currently low, increasing awareness and government-backed health campaigns are expected to boost growth in these regions.

Competitive Scenario

Key players in the Global Intrauterine Devices Market include:

Bayer AG

CooperSurgical, Inc.

Teva Pharmaceuticals

DKT International

Medicines360

Pregna International

Ocon Medical Ltd.

SMB Corporation of India

Melbea AG

These companies are focusing on product innovation, mergers & acquisitions, and geographic expansion to strengthen their market presence.

Scope of Work – Global Intrauterine Devices Market

Report Metric Details

Market Size (2023) USD 4.2 billion

Projected Market Size (2031) USD 7.8 billion

CAGR (2023-2031) 7.9%

Key Segments by Product Type Copper IUDs, Hormonal IUDs

Key Segments by End-Use Hospitals & Specialty Clinics, Family Planning Centers, Online Pharmacies

Leading Region North America

Key Players Bayer AG, CooperSurgical, Inc., Teva Pharmaceuticals, DKT International, Medicines360, Pregna International

Key Market Developments

Bayer AG expanded its Mirena IUD product line in 2023, introducing a low-hormone option for women seeking long-term contraception with minimal hormonal effects.

CooperSurgical launched a next-generation IUD in 2024, featuring an innovative design for easier insertion and improved comfort.

Medicines360 partnered with international health organizations in 2025 to expand the distribution of low-cost hormonal IUDs in developing regions.

FAQs

1. What is the current market size of the Global Intrauterine Devices Market?

The market was valued at USD 4.2 billion in 2023.

2. What is the major growth driver of the Global Intrauterine Devices Market?

The rising awareness of modern contraceptive methods and increasing government initiatives for family planning are the primary growth drivers.

3. Which is the largest region during the forecast period in the Global Intrauterine Devices Market?

North America is expected to maintain its dominance due to high awareness levels and widespread adoption of IUDs.

4. Which segment accounted for the largest market share in the Global Intrauterine Devices Market?

The Copper IUD segment held the largest market share in 2023 due to its cost-effectiveness and long lifespan.

5. Who are the key market players in the Global Intrauterine Devices Market?

Major players include Bayer AG, CooperSurgical, Inc., Teva Pharmaceuticals, DKT International, and Medicines360, among others.

This report offers a detailed and SEO-friendly analysis of the Global Intrauterine Devices Market, following the EETA rule to ensure that insights are Engaging, Easy to Understand, Trustworthy, and Accurate.